Cargando…
Lidocaine inhibits the progression of retinoblastoma in vitro and in vivo by modulating the miR-520a-3p/EGFR axis
Retinoblastoma (RB) is a common malignant tumor in children. Lidocaine is a local anesthetic and anti-arrhythmic drug, and has been reported to possess anti-tumor properties. MicroRNAs (miRs) are a group of endogenous small noncoding RNAs that have important roles in various biological processes via...
Autores principales: | Xia, Weiyi, Wang, Libo, Yu, Dongyi, Mu, Xing, Zhou, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625385/ https://www.ncbi.nlm.nih.gov/pubmed/31173241 http://dx.doi.org/10.3892/mmr.2019.10363 |
Ejemplares similares
-
Hsa_circ_0088212-mediated miR-520 h/APOA1 axis inhibits osteosarcoma progression
por: Liu, Feng, et al.
Publicado: (2021) -
LncRNA ZFAS1 contributes to osteosarcoma progression via miR-520b and miR-520e-mediated inhibition of RHOC signaling
por: Liu, Xiaofeng, et al.
Publicado: (2022) -
Lidocaine has antitumor effect on hepatocellular carcinoma via the circ_DYNC1H1/miR-520a-3p/USP14 axis
por: Liu, Hua, et al.
Publicado: (2021) -
Retraction of “Lidocaine has antitumor effect on hepatocellular carcinoma via the circ_DYNC1H1/miR-520a-3p/USP14 axis”
por: Liu, Hua, et al.
Publicado: (2022) -
circNFATC3 facilitated the progression of oral squamous cell carcinoma via the miR-520h/LDHA axis
por: Xie, Hongguo, et al.
Publicado: (2023)